Rituximab and intravenous immune globulin for desensitization during renal transplantation.

Vo, Ashley A

Rituximab and intravenous immune globulin for desensitization during renal transplantation. [electronic resource] - The New England journal of medicine Jul 2008 - 242-51 p. digital

Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

1533-4406

10.1056/NEJMoa0707894 doi


Adult
Antibodies--blood
Antibodies, Monoclonal--adverse effects
Antibodies, Monoclonal, Murine-Derived
Antigens, CD19--blood
Antigens, CD20--immunology
Creatinine--blood
Desensitization, Immunologic--methods
Drug Therapy, Combination
Female
Graft Rejection--epidemiology
HLA Antigens--immunology
Humans
Immunoglobulins, Intravenous--adverse effects
Immunologic Factors--adverse effects
Immunosuppression Therapy--methods
Kidney Transplantation--immunology
Male
Middle Aged
Rituximab
Survival Rate